China Post -- According to Timothy Rodell, CEO and president GlobelImmune, Inc, the biotechnology industry has seen major changes in the strategies and partnering of small biotech companies over the last 25 years.
China Post -- According to Timothy Rodell, CEO and president GlobelImmune, Inc, the biotechnology industry has seen major changes in the strategies and partnering of small biotech companies over the last 25 years.